Patentability of nanopharmaceuticals requires demonstrated enhanced therapeutic efficacy and robust safety and standardization data.
Patent protection for nano pharmaceuticals in India requires novelty, inventive step and industrial applicability while overcoming statutory exclusions for inventions prejudicial to health or the environment and for methods of medical treatment; applicants must demonstrate Enhanced Efficacy beyond mere particle-size reduction, provide standardized, reproducible testing and safety data, and align patenting strategies with TRIPS-consistent public-order and health exceptions. (AI Summary)
Patent protection for nano pharmaceuticals in India requires novelty, inventive step and industrial applicability while overcoming statutory exclusions for inventions prejudicial to health or the environment and for methods of medical treatment; applicants must demonstrate Enhanced Efficacy beyond mere particle-size reduction, provide standardized, reproducible testing and safety data, and align patenting strategies with TRIPS-consistent public-order and health exceptions. (AI Summary)
TaxTMI